Journal Information

Statistics

Follow this link to access the full text of the article

434
HEALTH-RELATED QUALITY OF LIFE OUTCOMES FROM THE PHASE 3 CANDOR STUDY COMPARING CARFILZOMIB, DEXAMETHASONE, AND DARATUMUMAB TO CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
D.S. Siegela, K. Weiselb, A. Zahlten-Kumelic, R. Medhekarc, S. Saprac, B. Dingc, X. Leleud
a John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, United States
b Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
c Amgen Inc., Thousand Oaks, United States
d Hôpital Claude Huriez, Lille, France
Read
1787
Times
was read the article
951
Total PDF
836
Total HTML
Share statistics
Article information
ISSN: 25311379
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 April 6 8 14
2024 March 27 22 49
2024 February 21 18 39
2024 January 16 25 41
2023 December 20 22 42
2023 November 23 30 53
2023 October 13 37 50
2023 September 22 35 57
2023 August 18 15 33
2023 July 17 17 34
2023 June 14 14 28
2023 May 21 13 34
2023 April 19 2 21
2023 March 21 12 33
2023 February 15 17 32
2023 January 12 8 20
2022 December 21 19 40
2022 November 22 28 50
2022 October 26 20 46
2022 September 34 24 58
2022 August 30 31 61
2022 July 14 34 48
2022 June 15 25 40
2022 May 16 22 38
2022 April 11 32 43
2022 March 12 14 26
2022 February 13 24 37
2022 January 9 13 22
2021 December 11 22 33
2021 November 14 17 31
2021 October 16 36 52
2021 September 20 31 51
2021 August 25 33 58
2021 July 22 35 57
2021 June 17 22 39
2021 May 17 34 51
2021 April 88 50 138
2021 March 30 32 62
2021 February 25 24 49
2021 January 10 9 19
2020 December 17 13 30
2020 November 16 12 28
Show all

Follow this link to access the full text of the article

Idiomas
Hematology, Transfusion and Cell Therapy